Navigation Links
Cadient Group Selected as Finalist in Medical Marketing & Media Awards
Date:9/21/2009

WEST CONSHOHOCKEN, Pa., Sept. 21 /PRNewswire/ -- Cadient Group, the premier strategic interactive marketing agency serving the healthcare industry, today announced that two web sites it developed and designed have been selected among five finalists in Medical Marketing & Media magazine's MM&M Awards for the Best Web Site category.

The MySYMBICORT.com web site developed by Cadient Group for AstraZeneca and the HipReplacement.com web site designed for DePuy Orthopaedics are among the five finalists in the category. Judged by industry "all-stars" from top pharmaceutical companies and agency service providers, the MM&M Award winners will be announced on October 29 at a black-tie gala at New York City's Tavern on the Green.

"Creating innovative and relevant web sites for pharmaceutical and healthcare companies is just one of many areas in which our agency excels," said Stephen Wray, president and CEO, Cadient Group. "We are honored that two of our projects have been selected as finalists this year for this prestigious award. Both web sites were just one component of successful interactive marketing campaigns we developed for these two clients."

About Cadient Group

Cadient Group is an interactive marketing network focused on the healthcare industry. Our companies align client needs with relevant innovation to deliver meaningful experiences and measurable results. Across Cadient Group, our strategic insight helps clients better utilize multi-channel marketing to enhance connections with consumer and professional audiences. Cadient Group clients consistently realize the full potential of their brand, franchise, and corporate healthcare communications. With Cadient Group, you'll Experience Results. For more information about Cadient Group, visit www.cadient.com.

    Media Contact:
    Karen Higgins
    A & E Communications, Inc. for Cadient Group
    khiggins@aandecomm.com
    610-831-5723


'/>"/>
SOURCE Cadient Group
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cadient Group Ranks on Inc. 5000 List of Fastest-Growing Companies for Third Consecutive Year
2. Digital Healthcare Specialist Cadient Group Ranked #2 on List of Full-service Advertising Agencies in the Philadelphia Region
3. Cadient Group Brings Home the Gold and Two Bronze Aster Awards
4. Cadient Interactive Expands Creative Leadership with New Associate Director
5. Cadient Groups GEL Interactive Technologies to Launch Immerse(SM) Exhibit 4.0 at EXHIBITOR2009
6. Cadient Groups GEL Interactive Technologies to Present and Exhibit at CBIs 5th Annual Forum
7. Cadient Group Recognized with Five Awards at 14th Annual Communicator Awards
8. Cadient Group Brings Home the Gold at 2008 Aster Awards
9. Cadient Group Announces Recent Executive Promotions
10. Dr M Group Selects Health Robotics Technology Over RIVA for all of its I.V. Compounding Centers in South East Asia
11. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):